- Home
- NAII vs IBIO Comparison
NAII vs IBIO Comparison
Compare NAII & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAII
- IBIO
- Stock Information
- Founded
- NAII 1980
- IBIO 2008
- Country
- NAII United States
- IBIO United States
- Employees
- NAII N/A
- IBIO N/A
- Industry
- NAII Medicinal Chemicals and Botanical Products
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- NAII Health Care
- IBIO Health Care
- Exchange
- NAII Nasdaq
- IBIO Nasdaq
- Market Cap
- NAII 26.0M
- IBIO 24.3M
- IPO Year
- NAII 1987
- IBIO N/A
- Fundamental
- Price
- NAII $4.05
- IBIO $3.48
- Analyst Decision
- NAII
- IBIO Strong Buy
- Analyst Count
- NAII 0
- IBIO 3
- Target Price
- NAII N/A
- IBIO $4.87
- AVG Volume (30 Days)
- NAII 4.9K
- IBIO 299.1K
- Earning Date
- NAII 02-14-2025
- IBIO 02-10-2025
- Dividend Yield
- NAII N/A
- IBIO N/A
- EPS Growth
- NAII N/A
- IBIO N/A
- EPS
- NAII N/A
- IBIO N/A
- Revenue
- NAII $121,853,000.00
- IBIO $375,000.00
- Revenue This Year
- NAII N/A
- IBIO $36.00
- Revenue Next Year
- NAII N/A
- IBIO $33.33
- P/E Ratio
- NAII N/A
- IBIO N/A
- Revenue Growth
- NAII N/A
- IBIO 650.00
- 52 Week Low
- NAII $4.02
- IBIO $1.05
- 52 Week High
- NAII $7.26
- IBIO $4.98
- Technical
- Relative Strength Index (RSI)
- NAII 36.48
- IBIO 55.25
- Support Level
- NAII $4.08
- IBIO $3.22
- Resistance Level
- NAII $4.19
- IBIO $3.76
- Average True Range (ATR)
- NAII 0.11
- IBIO 0.38
- MACD
- NAII -0.01
- IBIO 0.00
- Stochastic Oscillator
- NAII 8.76
- IBIO 56.41
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.